What challenges do vaccine trial participants face when experiencing adverse effects, and how does this impact accountability in the pharmaceutical industry?

Based on Brianne Dressen's experience as an AstraZeneca COVID-19 vaccine trial participant, individuals who suffer severe adverse effects often encounter significant challenges including lack of support from trial organizers and limited transparency in the injury reporting process. Her advocacy work highlights systemic issues where vaccine-injured participants struggle to receive recognition, proper medical care, and compensation for their injuries. This raises critical concerns about pharmaceutical accountability and the need for better support systems for trial participants who experience unexpected health consequences during vaccine development and testing phases.